For instance, the reappearance of the H3K27me3 mark in certain cancers has been linked to relapse, as observed in studies where eliminating H3K27me3 with histone methyltransferase inhibitors showed clinical benefit and reprogrammed the cancer epigenome [107]. The gene discussed is PRDM9; the disease is cancer.